Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Lanreotide 90 mg slow release formulation
Placebo
Locations
3
Belgium
AZ St. Lucas
Brugges, Belgium
ZOL Genk
Genk, Belgium
University Hospitals Leuven
Leuven, Belgium
Start Date
April 1, 2008
Primary Completion Date
December 2, 2013
Completion Date
December 2, 2013
Last Updated
January 27, 2023
NCT02971631
NCT02525705
NCT01637272
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions